The epidemiology and antimicrobial resistance of cholera cases in Iran during 2013
,
Abstract
Background and Objectives: Cholera is an endemic diarrheal disease in Iran, caused by Vibrio Cholerae. The epidemiology, transmission route, environmental determinants and antimicrobial resistant pattern of cholera have been changed during recent years. In this study the epidemiology and antimicrobial resistance of cholera in Iran during 2013 outbreak was investigated.
Materials and Methods: A retrospective, cross-sectional study was carried out using cholera national surveillance system collected data in 2013. Bacterial identification and antimicrobial susceptibility testing were done on 60 Vibrio cholerae isolates, serotype Inaba.
Results: During July to November 2013, 256 confirmed cholera cases were diagnosed by stool culture. Two hundred and eleven out of 256 (83%) cases were imported from Afghanistan and Pakistan. The prevalent age group was 16-30 years old, 90% were male, 98.8% affected by Inaba serotype and case fatality rate was 2.7%. The results of antimicrobial susceptibility testing on 60 V. cholerae, serotype Inaba showed that all isolates were resistant to nalidixic acid, tetracyclin and trimethoprim- sulfamethoxazole and intermediate resistance to erythromycin but sensitive to ciprofloxacin, cefixime and ampicillin.
Conclusion: Migrants from neighboring countries played a key role in cholera outbreak in Iran during 2013. The results of antimicrobial susceptibility testing on 60 V. cholerae, serotype Inaba showed an increasing resistance rate in comparison with previous years.
Outbreak C. Assessing the outbreak response and im- proving preparedness, 2004. World Health Organiza- tion, Geneva.
World Health Organization. Guidelines for the collec- tion of clinical specimens during field investigation of outbreaks. 2000.
Codeço CT. Endemic and epidemic dynamics of chol- era: the role of the aquatic reservoir. BMC Infect Dis 2001; 1:1.
Masoumi- Asl H , Gouya MM, Nabavi M, Aghili N.Epidemiology of typhoid fever in Iran during last five decades from 1962–2011. Iran J Public Health 2013;42:33.
Tavana AM, Fallah Z, Zahraee SM, Asl HM, Rahbar M, Mafi M, et al. Effects of climate on the cholera out- break in Iran during seven years (2000-2006). ATMPH 2008; 1:43-46.
Masoumi -Asl H, Gholami H, Rahbar M, Zahraei S.Invasive Vibrio cholerae 01 E1 Tor Inaba in a 3-day-old neonate: case report. Ann Trop Paediatr 2007; 27:153-154.
Masoumi-Asl H, Esteghamati A, Zahraei SM. The ef- fect of age group under 15 years on cholera morbidity during the past 10 years in Iran (1996-2005). Iran J Pediatr 2008; 18 (Suppl 1): 9-14 .
World Health Organization. Weekly epidemiological record: relevé épidémiologique hebdomadaire. WHO;2013; 31: 321-336.
Jafari NJ, Radfar M, Ghofrani H, Asl H. Epidemiolog- ical and Bacteriological Features of the Cholera Out- break in Iran (2005). J Med Sci 2007; 7:645-649.
Rahbar M, Sabourian R, Saremi M, Abbasi M, Ma- soumi Asl H, Soroush M. Epidemioloic and drug re- sistant pattern of Vibrio cholerae O1 Biotype EL Tor, Serotype Inaba during the summer of 2005 outbreak in Iran. J Ardabil Univ Med Sci 2007; 7:41-45 [In Persian].
Izadi S, Shakeri H, Roham P, Sheikhzadeh K. Cholera outbreak in southeast of Iran: routes of transmission in the situation of good primary health care services and poor individual hygienic practices. Jpn J Infect Dis 2006; 59:174-178.
Eshrati B, Zahraei S, Soroush M, Asl M, Afshani A, Ramezian M, et al. Use of meta-anaglysis to determin- ing the associated factors of an outbreak occurred in the summer 2005 in Iran. Arak Univ Med Sci 2008;11:99-108 [in persian].
Zahraei SM, Afshani Naghadeh M, Soroush M, Ma-soumi Asl H. Cholera epidemic in Iran , 2005. Iran Infect Dis Trop Med 2007; 12:(36) 1-4 [in persian].
Sargolzaie N, Kiani M. Cholera Outbreaks Evaluation in Sistan and Baluchestan Province of Iran. Int J Infect 2014; 1(1).
Rezaei N, Bagheri G-R, Mahmoudi M, Moin A-A, Dankoub M-A, Gazeran A. The epidemiology of vibrio cholerae in Zabol city, southeast of Iran. Arch Iran Med 2005; 8:197-201.
Shears P. Recent developments in cholera. Curr Opin Infect Dis 2001; 14:553-558.
Karami M, Maosumi Asl H, Mohammadin M, Rae- ofi H, Saghafipour A, Noroozi M, Khedmati E. Qom cholera outbreak in 2011: influential and determinant factors. IJE 2012; 8(3): 84 -92 [in persian].
Organization WH. Weekly epidemiological record:relevé épidémiologique hebdomadaire. WHO; 2014; 31,345-356.
Khazaei H-A, Rezaei N, Bagheri G-R, Moin A-A. A six-year study on Vibrio cholerae in southeastern Iran. Jpn J Infect Dis 2005; 58:8-10.
Pourshafie M, Bakhshi B, Ranjbar R, Sedaghat M, Sa- deghifard N, Yazdi JZ, et al. Dissemination of a single Vibrio cholerae clone in cholera outbreaks during 2005 in Iran. J Med Microbiol 2007; 56:1615-1619.
Hajia M, Rahbar M, Farzami MR, Asl HM, Dolatyar A, Imani M, et al. Assessing clonal correlation of epidem- ic Vibrio cholerae isolates during 2011 in 16 provinces of Iran. Curr Microbiol 2015; 70:408-414.
| Files | ||
| Issue | Vol 8 No 4 (2016) | |
| Section | Articles | |
| Keywords | ||
| Cholera Epidemiology Antimicrobial Resistance Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
